These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

370 related items for PubMed ID: 11401480

  • 1. MEK/ERK-mediated proliferation is negatively regulated by P38 map kinase in the human pancreatic cancer cell line, PANC-1.
    Ding XZ, Adrian TE.
    Biochem Biophys Res Commun; 2001 Mar 30; 282(2):447-53. PubMed ID: 11401480
    [Abstract] [Full Text] [Related]

  • 2. Multiple signal pathways are involved in the mitogenic effect of 5(S)-HETE in human pancreatic cancer.
    Ding XZ, Tong WG, Adrian TE.
    Oncology; 2003 Mar 30; 65(4):285-94. PubMed ID: 14707447
    [Abstract] [Full Text] [Related]

  • 3. Growth factor-dependent activation of the MAPK pathway in human pancreatic cancer: MEK/ERK and p38 MAP kinase interaction in uPA synthesis.
    Lee KH, Hyun MS, Kim JR.
    Clin Exp Metastasis; 2003 Mar 30; 20(6):499-505. PubMed ID: 14598883
    [Abstract] [Full Text] [Related]

  • 4. Role of MAP kinase pathways in mediating IL-6 production in human primary mesangial and proximal tubular cells.
    Leonard M, Ryan MP, Watson AJ, Schramek H, Healy E.
    Kidney Int; 1999 Oct 30; 56(4):1366-77. PubMed ID: 10504489
    [Abstract] [Full Text] [Related]

  • 5. Activation of JNK, p38 and ERK mitogen-activated protein kinases by chromium(VI) is mediated through oxidative stress but does not affect cytotoxicity.
    Chuang SM, Liou GY, Yang JL.
    Carcinogenesis; 2000 Aug 30; 21(8):1491-500. PubMed ID: 10910949
    [Abstract] [Full Text] [Related]

  • 6. Neurotensin stimulates protein kinase C-dependent mitogenic signaling in human pancreatic carcinoma cell line PANC-1.
    Guha S, Lunn JA, Santiskulvong C, Rozengurt E.
    Cancer Res; 2003 May 15; 63(10):2379-87. PubMed ID: 12750255
    [Abstract] [Full Text] [Related]

  • 7. MEK inhibition of pancreatic carcinoma cells by U0126 and its effect in combination with sulindac.
    Yip-Schneider MT, Schmidt CM.
    Pancreas; 2003 Nov 15; 27(4):337-44. PubMed ID: 14576498
    [Abstract] [Full Text] [Related]

  • 8. 12-lipoxygenase metabolite 12(S)-HETE stimulates human pancreatic cancer cell proliferation via protein tyrosine phosphorylation and ERK activation.
    Ding XZ, Tong WG, Adrian TE.
    Int J Cancer; 2001 Dec 01; 94(5):630-6. PubMed ID: 11745456
    [Abstract] [Full Text] [Related]

  • 9. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
    Zhang YX, Kong CZ.
    Zhonghua Yi Xue Za Zhi; 2008 Jan 22; 88(4):271-5. PubMed ID: 18361842
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of extracellular signal-regulated kinase (ERK) mediates cell cycle phase independent apoptosis in vinblastine-treated ML-1 cells.
    Stadheim TA, Xiao H, Eastman A.
    Cancer Res; 2001 Feb 15; 61(4):1533-40. PubMed ID: 11245462
    [Abstract] [Full Text] [Related]

  • 11. Pancreatic stellate cell activation by ethanol and acetaldehyde: is it mediated by the mitogen-activated protein kinase signaling pathway?
    McCarroll JA, Phillips PA, Park S, Doherty E, Pirola RC, Wilson JS, Apte MV.
    Pancreas; 2003 Aug 15; 27(2):150-60. PubMed ID: 12883264
    [Abstract] [Full Text] [Related]

  • 12. Differential effects of interleukin-3 and interleukin-1 on the proliferation and interleukin-6 protein secretion of acute myeloid leukemic cells; the involvement of ERK, p38 and STAT5.
    Birkenkamp KU, Esselink MT, Kruijer W, Vellenga E.
    Eur Cytokine Netw; 1999 Dec 15; 10(4):479-90. PubMed ID: 10586114
    [Abstract] [Full Text] [Related]

  • 13. CTGF/Hcs24 induces chondrocyte differentiation through a p38 mitogen-activated protein kinase (p38MAPK), and proliferation through a p44/42 MAPK/extracellular-signal regulated kinase (ERK).
    Yosimichi G, Nakanishi T, Nishida T, Hattori T, Takano-Yamamoto T, Takigawa M.
    Eur J Biochem; 2001 Dec 15; 268(23):6058-65. PubMed ID: 11732999
    [Abstract] [Full Text] [Related]

  • 14. Regulation of hepatocyte growth factor-mediated urokinase plasminogen activator secretion by MEK/ERK activation in human stomach cancer cell lines.
    Lee KH, Choi EY, Kim MK, Hyun MS, Jang BI, Kim TN, Kim SW, Song SK, Kim JH, Kim JR.
    Exp Mol Med; 2006 Feb 28; 38(1):27-35. PubMed ID: 16520550
    [Abstract] [Full Text] [Related]

  • 15. Signaling through the p38 and p42/44 mitogen-activated families of protein kinases in pancreatic beta-cell proliferation.
    Burns CJ, Squires PE, Persaud SJ.
    Biochem Biophys Res Commun; 2000 Feb 16; 268(2):541-6. PubMed ID: 10679240
    [Abstract] [Full Text] [Related]

  • 16. LTB4 stimulates growth of human pancreatic cancer cells via MAPK and PI-3 kinase pathways.
    Tong WG, Ding XZ, Talamonti MS, Bell RH, Adrian TE.
    Biochem Biophys Res Commun; 2005 Sep 30; 335(3):949-56. PubMed ID: 16105664
    [Abstract] [Full Text] [Related]

  • 17. Roles of JNK, p38 and ERK mitogen-activated protein kinases in the growth inhibition and apoptosis induced by cadmium.
    Chuang SM, Wang IC, Yang JL.
    Carcinogenesis; 2000 Jul 30; 21(7):1423-32. PubMed ID: 10874022
    [Abstract] [Full Text] [Related]

  • 18. Paclitaxel induces prolonged activation of the Ras/MEK/ERK pathway independently of activating the programmed cell death machinery.
    Okano J, Rustgi AK.
    J Biol Chem; 2001 Jun 01; 276(22):19555-64. PubMed ID: 11278851
    [Abstract] [Full Text] [Related]

  • 19. Pharmacologic inhibition of RAF-->MEK-->ERK signaling elicits pancreatic cancer cell cycle arrest through induced expression of p27Kip1.
    Gysin S, Lee SH, Dean NM, McMahon M.
    Cancer Res; 2005 Jun 01; 65(11):4870-80. PubMed ID: 15930308
    [Abstract] [Full Text] [Related]

  • 20. The p38 MAP kinase inhibitor SB203580 enhances nuclear factor-kappa B transcriptional activity by a non-specific effect upon the ERK pathway.
    Birkenkamp KU, Tuyt LM, Lummen C, Wierenga AT, Kruijer W, Vellenga E.
    Br J Pharmacol; 2000 Sep 01; 131(1):99-107. PubMed ID: 10960075
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.